Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01068548 · ClinicalTrials.gov registry record · NA
Reducing Length of Stay for Veterans Hospitalized With Pneumonia
A NA study of Pneumonia, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
- 1
- Study location
NCT01068548 is a NA study of Pneumonia that has completed, run by VA Office of Research and Development. The registered enrollment target is 129 participants, below the 4,517-participant average among 47 other Pneumonia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01068548, a NA study of Pneumonia, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study to implement a computer based intervention to safely reduce length of hospital stay and time to conversion to oral antibiotics for patients with pneumonia.
Conditions Studied
Interventions
- OTHER reminder
Study Locations (1)
Texas
- South Texas Health Care System, San Antonio, TX - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2011-02 |
| Est. Completion | 2011-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01068548
The ClinicalTrials.gov registry entry for NCT01068548 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,517-participant average among 47 other Pneumonia trials with a reported enrollment target (97% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pneumonia appearing as the primary indexed condition, and to 1 intervention - of which reminder is the first listed.
NCT01068548 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01068548 about?
NCT01068548 is a clinical study titled "Reducing Length of Stay for Veterans Hospitalized With Pneumonia". This is a pilot study to implement a computer based intervention to safely reduce length of hospital stay and time to conversion to oral antibiotics for patients with pneumonia.
What is the current status of trial NCT01068548?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2011-02. Estimated completion is 2011-11.
What conditions does trial NCT01068548 study?
This clinical trial studies the following conditions: Pneumonia.
What interventions are being tested in trial NCT01068548?
The interventions under investigation include: reminder (OTHER).
Who is sponsoring clinical trial NCT01068548?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01068548 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
Extending Dental Care to Nursing Home Residents to Reduce Mouth Infections and Incidence of Pneumonia and Improve Diabetic Glucose Control
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
-
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
RECRUITING · NA
-
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.